Overview

Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This is a research project to test two study techniques among healthy adults. The procedures look at how blood flow is controlled by substances in blood vessels.
Phase:
N/A
Details
Lead Sponsor:
Crystal A. Gadegbeku
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
University of Michigan
Treatments:
Adrenergic Agents
Nitric Oxide
Oxymetazoline
Phenylephrine